Analyst Ratings for Cardiome Pharma (CRME)

CRME Rating Summary

CRME Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRME
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.25 (+189.5%) * Over Last 12-Mos
Rating Score: 5.5 / 10   Percentile Rank: 62%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/1/2016 H.C. Wainwright New Coverage Buy
(N/A)
9.50
(N/A)
4.68 2.85 -39.1% Details
1/8/2015 Brean Capital
» Updated 8/15/2016
New Coverage Buy
(N/A)
7.00
(10.00)
9.30 2.85 -69.35% Details
Like CRME Ratings? Also take a look at STDY, AGN

CRME Ratings News